Farther Finance Advisors, LLC Novo Cure LTD Transaction History
Farther Finance Advisors, LLC
- $5 Trillion
- Q2 2025
A detailed history of Farther Finance Advisors, LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 494 shares of NVCR stock, worth $8,985. This represents 0.0% of its overall portfolio holdings.
Number of Shares
494
Previous 697
29.12%
Holding current value
$8,985
Previous $12.2 Million
27.99%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding NVCR
# of Institutions
266Shares Held
79.4MCall Options Held
970KPut Options Held
118K-
Black Rock Inc. New York, NY12.1MShares$221 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.3MShares$205 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA8.95MShares$163 Million0.03% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT5.52MShares$100 Million8.14% of portfolio
-
Capital World Investors Los Angeles, CA5.22MShares$94.9 Million0.02% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.91B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...